Review of management of type 2 diabetes mellitus. (Q33536960)

27 July 2017

Review of management of type 2 diabetes mellitus. (English)

1 reference

27 July 2017

1 reference

Peterson GM

2

0 references

author name string

Yap WS

1

1 reference

27 July 2017

Vial JH

3

1 reference

27 July 2017

Randall CT

4

1 reference

27 July 2017

Greenaway TM

5

1 reference

27 July 2017

1 December 1998

1 reference

Journal of Clinical Pharmacy and Therapeutics

27 July 2017

1 reference

27 July 2017

23

1 reference

27 July 2017

6

1 reference

27 July 2017

457-465

1 reference

Metformin-associated nonketotic metabolic acidosis

27 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00185.X

Drug treatment of non-insulin-dependent diabetes mellitus in the 1990s. Achievements and future developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00185.X

Comparative tolerability profiles of oral antidiabetic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00185.X

Slow elimination of glyburide in NIDDM subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00185.X

Hypoglycemic activity of glyburide (glibenclamide) metabolites in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00185.X

Hypoglycaemic admissions among diabetic patients in Soweto, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00185.X

Benefits and Risks With Glyburide and Glipizide in Elderly NIDDM Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00185.X

Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00185.X

Comparison of efficacy, secondary failure rate, and complications of sulfonylureas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00185.X

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00185.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00185.X

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00185.X

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00185.X

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00185.X

Trends in use of oral hypoglycemic agents 1964-1986.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00185.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00185.X

Insulin therapy in type II diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00185.X

Management of Non-Insulin-Dependent Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1998.00185.X

10.1046/J.1365-2710.1998.00185.X

21 January 2018

Identifiers

DOI

1 reference

27 July 2017

1 reference